Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 30, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net income	$ 94,342	$ 58,683
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	120,219	114,370
Stock-based compensation	46,261	40,945
Excess tax benefit from share-based payment arrangements	(18,396)	(3,636)
Loss on disposal or impairment of long-lived assets	1,781	2,385
Amortization of premium/discount on investments	7,674	7,075
Changes in operating assets and liabilities:
Accounts receivable, net	(29,829)	(29,624)
Inventories	(53,511)	(6,866)
Prepaid expenses and other assets	13,008	(6,472)
Accounts payable, trade	29,016	33,495
Accrued salaries and wages and other liabilities	17,605	13,715
Net cash provided by operating activities	228,170	224,070
Cash flows from investing activities:
Purchases of property and equipment	(119,614)	(55,406)
Purchases of available-for-sale investments	(510,401)	(533,884)
Proceeds from maturities of available-for-sale investments	365,005	297,740
Proceeds from sale of property and equipment	117	301
Proceeds from sale of available-for-sale investments	22,387	36,089
Purchases of patent and licensing rights	(14,755)	(15,794)
Net cash used in investing activities	(257,261)	(270,954)
Cash flows from financing activities:
Net proceeds from issuance of common stock	89,476	43,352
Excess tax benefit from share-based payment arrangements	18,396	3,636
Repurchases of common stock	(107)	(638)
Net cash provided by financing activities	107,765	46,350
Effects of foreign exchange changes on cash and cash equivalents	95	87
Net increase (decrease) in cash and cash equivalents	78,769	(447)
Cash and cash equivalents:
Beginning of period	190,069	178,885
End of period	$ 268,838	$ 178,438